Operating Model Transformation

Who it's for: Pharma, medtech, and biotech companies specifically, industries with heavy regulatory oversight (MLR review, compliance, GxP), complex cross-functional workflows (medical, finance, commercial, R&D, regulatory), and historically slower tech adoption due to risk sensitivity.

What the service actually does, based on the two levers named:

1. Process re-design: Not just "add AI on top of what you do," but going in and re-architecting how work actually flows:

   • which steps exist

   • why and where the bottlenecks and redundant reviews are

   • what could be eliminated, automated, or restructured before (or instead of) layering in new tools

2. Employee upskilling: Building the internal capability (skills, confidence, new working habits) so teams can actually use AI tools effectively and sustainably, rather than depending indefinitely on outside vendors. This addresses the common failure mode where a company buys AI tools but employees don't adopt them.

The outcome : The goal isn't a pilot or a proof-of-concept in one team, but company-wide, embedded adoption: consistent practices, understanding, and usage spanning multiple departments, not just an innovation lab.